Publicaciones en colaboración con investigadores/as de Universidad de Jaén (74)

2022

  1. Circular Sponge against miR-21 Enhances the Antitumor Activity of Doxorubicin against Breast Cancer Cells

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

  2. Synthetic Circular miR-21 Sponge as Tool for Lung Cancer Treatment

    International Journal of Molecular Sciences, Vol. 23, Núm. 6

2020

  1. Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)

    Cancer Gene Therapy

  2. Nanoparticles in Colorectal Cancer Therapy: Latest In Vivo Assays, Clinical Trials, and Patents

    AAPS PharmSciTech, Vol. 21, Núm. 5

  3. Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer

    Cancer Gene Therapy, Vol. 27, Núm. 9, pp. 657-668

2019

  1. Double origin of the extensor hallucis longus muscle: a case report

    Surgical and Radiologic Anatomy, Vol. 41, Núm. 12, pp. 1421-1423

  2. The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview

    Cancer Biology and Medicine, Vol. 16, Núm. 4, pp. 688-699

2018

  1. DNA methylation patterns as molecular biomarkers: An overview in colorectal cancer

    European Journal of Anatomy, Vol. 22, Núm. 4, pp. 303-316

  2. Downregulated microRNAs in the colorectal cancer: Diagnostic and therapeutic perspectives

    BMB Reports

  3. Latest in Vitro and in Vivo Assay, Clinical Trials and Patents in Cancer Treatment using Curcumin: A Literature Review

    Nutrition and Cancer, Vol. 70, Núm. 4, pp. 569-578

  4. Proteomic biomarkers in body fluids associated with pancreatic cancer

    Oncotarget, Vol. 9, Núm. 23, pp. 16573-16587

2017

  1. Gastrointestinal stromal tumours: An actualized overview

    European Journal of Anatomy, Vol. 21, Núm. 2, pp. 97-112

  2. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study

    European Journal of Pharmaceutical Sciences, Vol. 102, pp. 24-34

  3. Paclitaxel-loaded hollow-poly(4-vinylpyridine) nanoparticles enhance drug chemotherapeutic efficacy in lung and breast cancer cell lines

    Nano Research, Vol. 10, Núm. 3, pp. 856-875

  4. Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro

    Scientific Reports, Vol. 7, Núm. 1

  5. Untargeted LC-HRMS-based metabolomics for searching new biomarkers of pancreatic ductal adenocarcinoma: A pilot study

    SLAS Discovery, Vol. 22, Núm. 4, pp. 348-359

2016

  1. Current status of immunotherapy treatments for pancreatic cancer

    Journal of Clinical Gastroenterology, Vol. 50, Núm. 10, pp. 836-848

  2. Last advances in nanocarriers-based drug delivery systems for colorectal cancer

    Current Drug Delivery, Vol. 13, Núm. 6, pp. 830-838

2015

  1. Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(Butylcyanoacrylate) nanoparticles

    International Journal of Nanomedicine, Vol. 10, pp. 1291-1306

  2. Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(Butylcyanoacrylate) nanoparticles

    Drug Design, Development and Therapy, Vol. 9, pp. 6433-6444